EGFR Inhibitor-associated Rash

Clinical trial pipeline · Data from ClinicalTrials.gov

See which EGFR Inhibitor-associated Rash trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 3 trials

RecruitingPhase 2

NCT05639933

Study to Investigate the Efficacy, Safety, and Tolerability of Topical HT-001 for the Treatment of Skin Toxicities Assoc…

The goal of this clinical trial is to learn about HT-001 Topical Gel for treatment of EGFR inhibitor-induced skin toxicities. The main questions it aims to answ…

United States152 participantsStarted 2023-07-19

Treatment: HT-001 2% Topical Gel, HT-001 1% Topical Gel

RecruitingPhase 1/2

NCT06830863

A Study to Evaluate Topical ATR04-484 for EGFRi-Associated Dermal Toxicity

The goal of this randomized clinical trial is to learn if topical treatment with ATR04-484 can treat skin rash in patients undergoing EGFR inhibitor (EGFRi) the…

United States32 participantsStarted 2025-08-25

Treatment: ATR04-484, Vehicle

RecruitingPhase 2

NCT06818058

TAR-0520 Gel in EGFR Inhibitor-induced Folliculitis

A Phase II, multicentric, randomized, double-blind, placebo-controlled, parallel- group trial to confirm the good safaty profile and to explore the preventive e…

France60 participantsStarted 2025-01-20

Treatment: Brimonidine tartrate Gel, Placebo gel (no Brimonidine tartrate)

All recent trials (8 shown)

UnknownPhase 2

NCT04759664

LUT014 for the Reduction of Dose-Limiting Acneiform Lesions Associated With EGFRI Treatment of mCRC

The study evaluates the efficacy and safety of two strengths of LUT014 Gel topically applied once a day for 4 weeks, compared to placebo, in metastatic colorect…

United States117 participantsStarted 2021-04-12

Treatment: LUT014 Gel (Dose 1), LUT014 Gel (Dose 2)

CompletedPhase 2

NCT04239846

Prophylactic Treatment of Skin Rash Associated With EGFR Inhibitor Therapy

Epidermal growth factor receptor inhibitor (EGFRI) therapy for cancer is associated with potentially severe face and trunk skin acneiform rash. Severe or persis…

Taiwan74 participantsStarted 2019-10-02

Treatment: AC-701 Topical Gel 0.3%, Placebo Gel

EGFR Inhibitor-associated Rash

Trial phase breakdown

Trial status

Actively recruiting — 3 trials

Study to Investigate the Efficacy, Safety, and Tolerability of Topical HT-001 for the Treatment of Skin Toxicities Assoc…

A Study to Evaluate Topical ATR04-484 for EGFRi-Associated Dermal Toxicity

TAR-0520 Gel in EGFR Inhibitor-induced Folliculitis

All recent trials (8 shown)

LUT014 for the Reduction of Dose-Limiting Acneiform Lesions Associated With EGFRI Treatment of mCRC

Prophylactic Treatment of Skin Rash Associated With EGFR Inhibitor Therapy

Trial phase breakdown

Trial status

Actively recruiting — 3 trials

Study to Investigate the Efficacy, Safety, and Tolerability of Topical HT-001 for the Treatment of Skin Toxicities Assoc…

A Study to Evaluate Topical ATR04-484 for EGFRi-Associated Dermal Toxicity

TAR-0520 Gel in EGFR Inhibitor-induced Folliculitis

All recent trials (8 shown)

LUT014 for the Reduction of Dose-Limiting Acneiform Lesions Associated With EGFRI Treatment of mCRC

Prophylactic Treatment of Skin Rash Associated With EGFR Inhibitor Therapy

Safety, Tolerability and Systemic Absorption of Menadione Topical Lotion for Epidermal-Growth-Factor-Receptor (EGFR) Inh…

Prevention of Drug Rash From Certain Cancer Therapies Using Tretinoin Cream

Regenecare® Wound Gel in Treating Rash in Patients Receiving Cetuximab or Other Epidermal Growth Factor Receptor Inhibit…